Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization Riad Salem, Margaret.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.

Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study Robert J. Lewandowski, MD, Ahsun Riaz,

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Saurabh Dawra, Vishal Sharma, Usha Dutta

Chemoembolization and Radioembolization for Hepatocellular Carcinoma

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Michael Camilleri, Anthony Lembo, David A. Katzka

Shou–Jiang Tang, Feriyl Bhaijee

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Lauren A. Beste, George N. Ioannou, Yin Yang, Michael F

Amit G. Singal, Jasmin A. Tiro, Samir Gupta

Leigh Ann White, Joseph Menzin, Jonathan R

Volume 141, Issue 2, Pages e2 (August 2011)

Andree Koop, Michael J. Bartel, Dawn Francis

Volume 151, Issue 6, Pages e2 (December 2016)

Should the Reflex Be Reflux

Ampullary Carcinoid: Diagnostic Challenges and Update on Management

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage

Miles Basil, Anita Pudusseri, Robert Lowe

Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis Hiroyuki Matsubayashi, Toru Matsui, Hiroyuki.

Volume 138, Issue 1, Pages (January 2010)

Jessica L. Mellinger, Michael L. Volk

Activity-Based Costing and Management in a Hospital-Based GI Unit

Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A

Amie L. Harvey, Tommy Yen, Anand Kunda

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

Joanna Gibson, Jill Lacy, Ellen Matloff, Marie Robert

Miho Sakumura, Kazuto Tajiri, Toshiro Sugiyama

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima

New Models of Gastroenterology Practice

Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Lance L. Stein, MD, Marty T. Sellers, MD, MPH

George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B

An Asymptomatic, Radiographically Undetected Hepatocellular Carcinoma That Presented as a Large Retropancreatic Mass Najat Mourra, Lionel Arrive, François.

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases Michael D.

Volume 140, Issue 2, Pages e2 (February 2011)

David H. Bruining, William J. Sandborn

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis Michael J. Stewart, Cynthia.

Isolated Metastasis of Hepatocellular Carcinoma in the Right Ventricle

Peter Bytzer Clinical Gastroenterology and Hepatology

Cholelithiasis in a Patient With History of Cholecystectomy

An Unusual Presentation of Hematemesis: A Presentation of Maxillary Metastasis From Hepatocellular Carcinoma Ming–Jong Bair, Wei–Yi Lei, Chien–Lin Chen

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Pauline Copin, Maxime Ronot, Valérie Vilgrain

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization Madhu Subramanian, Amit G. Singal,

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

Hematochezia From Metastasis of Hepatocellular Carcinoma to Colon in a Patient Who Underwent Liver Transplantation Ruhail Kohli, Andrei S. Purysko, Binu.

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Issue Highlights Clinical Gastroenterology and Hepatology

Preeth Jayaram, Alex Shindel, James Buxbaum

Black and White Liver Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Rintaro Hashimoto, Akimichi Chonan

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization Riad Salem, Margaret Gilbertsen, Zeeshan Butt, Khairuddin Memon, Michael Vouche, Ryan Hickey, Talia Baker, Michael M. Abecassis, Rohi Atassi, Ahsun Riaz, David Cella, James L. Burns, Daniel Ganger, Al B. Benson, Mary F. Mulcahy, Laura Kulik, Robert Lewandowski Clinical Gastroenterology and Hepatology Volume 11, Issue 10, Pages 1358-1365.e1 (October 2013) DOI: 10.1016/j.cgh.2013.04.028 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 (A) Change in FACT-Hep score between treatment groups. (B) Change in FACT-General score between treatment groups. (C) Change in FACT Hepatobiliary–Pancreatic Symptom Index (FHSI). (D) Change in overall QoL between treatment groups. Clinical Gastroenterology and Hepatology 2013 11, 1358-1365.e1DOI: (10.1016/j.cgh.2013.04.028) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Change in ESS between treatment groups. Clinical Gastroenterology and Hepatology 2013 11, 1358-1365.e1DOI: (10.1016/j.cgh.2013.04.028) Copyright © 2013 AGA Institute Terms and Conditions